Intra-Cellular Therapies, Inc.
USD131.87
+0.00 (+0.00%)
CEO
Sharon Mates
IPO Date
2014-01-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$131.87
Prev. Close
$131.87
Day Low
$131.87
Day High
$131.87
52W Low
$64.09
52W High
$131.98
Market Cap
$14.05B
Volume
16.04M
| 20,000 |
| $26.58 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 20,000 | $38.35 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 20,000 | $20.39 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 20,000 | $22.02 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 20,000 | $43.45 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 16,757 | $55.48 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 7,009 | $63.79 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 4,322 | $67.77 |
| 2 Apr 2025 | VAN NOSTRAND ROBERT L | director | D-Return | Disposed | 2,951 | $0.00 |
| $1,001 - $15,000 |
| 8 Apr 2025 | Gilbert Cisneros | Gilbert Cisneros | Sale | $1,001 - $15,000 |
| 11 Feb 2025 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 9 Jul 2024 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 10 Jan 2022 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |